1 / 54

Fundamentals of Biotechnology

Fundamentals of Biotechnology. Molecular Diagnostics. Molecular Diagnostics. The success of modern medicine and agriculture depends on the detection of specific molecules e.g. Viruses Bacteria Fungi Parasites Proteins and Small Molecules In water, plants, soil and humans.

della
Download Presentation

Fundamentals of Biotechnology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Fundamentals of Biotechnology Molecular Diagnostics

  2. Molecular Diagnostics • The success of modern medicine and agriculture depends on the detection of specific molecules e.g. • Viruses • Bacteria • Fungi • Parasites • Proteins and Small Molecules • In water, plants, soil and humans.

  3. Characteristics of a Detection System • A good detection system should have 3 qualities: • Sensitivity • Specificity • Simplicity • Sensitivity:means that the test must be able to detect very small amounts of target even in the presence of other molecules. • Specificity: the test yields a positive result for the target molecule only. • Simplicity: the test must be able to run efficiently and inexpensively on a routine basis.

  4. Comparison of Methods Used to Diagnose Parasite Infections

  5. Immunological Diagnostic Procedures • Immunological diagnostic procedures are often used to: • Test drugs • Monitor cancers • Detect pathogens Limitation if the target is protein part ( biochemical) • ELISA(Enzyme Linked Immunosorbent Assay) • This involves the reaction of an antibody with an antigen and a detection system to determine if a reaction has occurred. • ELISA involves: • Binding of the testmolecule or organism to a solid support e.g. micro titer plate.

  6. ELISA • Addition of a specific antibody(primary antibody) which will bind to the test molecule if it is present. • Washing to remove unbound molecules. • Addition of secondary antibodywhich will bind to the primary antibody. • The secondary antibody usually has attached to it an enzyme e.g. alkaline phosphatase. • Washto remove unbound antibody. • Addition of a colourless substratewhich will react with the secondary antibody to give a colour reactionwhich indicates a positive result.

  7. ELISA

  8. Antigens and Antibodies • Most antigens have many antigenic determinants or epitopes • Injecting antigens into mammal produces serum of polyclonal antibodies • Bind to many different epitopes and with different affinities • A uniform, high affinity, highly specific antibody preparation would be preferable • Monoclonal antibodies

  9. Drawbacks of Polyclonal Abs • In diagnostics: • The amount of different Abs within a polyclonal preparation may be very from one batch to the next • they cant be used to distinguish between two similar targets • e.g. when the difference b.w the pathogenic (target) and Non Pathogenic one (non target) is single determined.

  10. Monoclonal Antibodies • B Cell can’t be culture but their hybrid can. • Each B cell produces only one antibody (all of the molecules produced are identical) • A clone of B cells therefore all produce identical antibodies • Identify the proper clone and the culture of these cells produces a monoclonal antibody against the desired epitope

  11. HAT Selection Cells obtain purines and pyrimidines by either of two ways • De novo biosynthesis requiring dihydrofolate reductase (DHFR) activity • Salvage requiring HGPRTase (hypoxanthine guanine phosphoribosyl transferase) for purines • Drug aminopterin inhibits DHFR forcing cells to utilize salvage pathways • HGPRTase (-) cells cannot salvage purines (hypoxanthine or guanine)

  12. HAT Selection Procedure • HAT • Hypoxanthine • Aminopterin • Thymidine • Protocol • Immunize mouse with Ag • Isolate spleen (B cells) • Fuse with HGPRT- myeloma tumor cells • Select for actively dividing HGPRT+ cells on HAT medium

  13. Screening for Monoclonal Antibody Production • HGPRT+ clones screened by immunoassay (use in ELISA protocol) • Clones that produce antibody binding to target antigen cultured and further characterized

  14. Targets for Monoclonal Antibody-based Diagnostic Tests

  15. DNA Diagnostic Systems • Presence of an organisms genetic material is a strong indicator of the presence of the organism or infectious agent • DNA Diagnostic Systems include: • DNA Hybridization • PCR • Restriction endonuclease analysis • RAPD (random amplified polymorphic DNA) • DNA fingerprinting

  16. DNA Hybridization • Bacterial and viral pathogens may be pathogenic because of the presence of specific genes or sets of genes. • Genetic diseases often are due to mutations or absence of particular gene or genes. • These genes (DNA) can be used as diagnostic tools. • This involves using a DNA probe during DNA hybridization. • Nucleic Acid Hybridization diagnostic test has 3 critical elements: • Probe DNA, Target DNA, Signal detection.

  17. DNA Hybridization • For DNA hybridization: • A probe is needed which will anneal to the target nucleic acid. • Attach the targetto a solid matrix e.g. membrane. • Denaturation ofboth the probe and target. • Add the denatured probe in a solution to the target. • If there is sequence homologybetween the target and the probe, the probe will hybridize or anneal to the target. • Detection of the hybridized probe e.g. by autoradiography, chemiluminsence or colorimetric.

  18. DNA Diagnostic Probes • DNA or RNA: long (>100 nts) or short (<50 nts): and chemically synthesis, Cloned intact gene, or isolated region of a gene • Useful for detection of parasites • Distinguish readily between subtypes • Distinguish readily between present and past infections (not necessarily easily done by some ELISA protocols) • PCR makes highly sensitive

  19. Nonradioactive Detection Procedures • Chemiluminescent detection of bound DNA probe • Biotin-labeled nucleotides • Streptavidin (SA) binds biotin • Alkaline phosphatase conjugated to biotin also binds SA • AP cleaves small molecule releasing light

  20. Detection by Fluorescent Dyes • Fluorescent dye attached to PCR primer(s) • PCR product now fluorescent-labeled • Detect following laser activation

  21. Molecular Beacons • Probe • Palindromic region • Fluorophore • Quencher • Binding of probe to target sequence separates quencher from fluorophore • Laser activation for detection

  22. Molecular Beacons • Molecular beacons with different fluorophores allow for simultaneous testing for multiple sequences

  23. Detection of Heterozygotes • Use of multiple fluorophores and lasers

  24. Detection of Malaria • Malaria is caused by the parasite Plasmodium falciparum. • The parasite infects and destroys red bloodcells. • Symptoms include fever, rashes and damage to brain, kidney and other organs. • Current treatment involves microscopic observationsof blood smears, which is labour intensive. • Other methods e.gELISAdoes not differentiate between past and present infection.

  25. Detection of Malaria • A DNA diagnostic system would only measure current infection. • The procedure involves: • A genomic libraryof the parasite was screened with probes for parasitic DNA. • The probes which hybridized stronglywere tested further. • The probes were tested for their ability to hybridize to other Plasmodium specieswhich do not cause malaria and to human DNA.

  26. Detection of Malaria • Probes which hybridized to P. falciparum only could be used as a diagnostic tool. • The probe was able to detect 10 pg of purified DNA or 1 ng of DNA in blood smear. • Other DNA probes were developed for the following diseases: • Salmonella typhi (food poisoning) • E. coli (gastroenteritis) • Trypanosoma cruzi (chagas’ disease) (188bp DNA present in multiple copies)

  27. Polymerase Chain Reaction • PCR uses 2 sequence specific oligionucleotide primers to amplify the target DNA. • The presence of the appropriate amplified size fragment confirms the presence of the target. • Specific primers are now available for the detection of many pathogens including bacteria (E. coli, M. tuberculosis), viruses (HIV) and fungi.

  28. Using PCR to Detect for HIV • RT-PCR (reverse transcriptase PCR). • HIV has a ssRNA genome. • Lyse plasma cells from the potentially infected person to release HIV RNA genome. • The RNA is precipitated using isoproponal. • Reverse transciptase is used to make a cDNAcopy of the RNA of the virus. • This cDNA is used as a template to make dsDNA.

  29. RT-PCR Diagnosis of HIV

  30. Using PCR to Detect for HIV • Specific primers are used to amplify a 156 bp portion of the HIVgag gene. • Using standards the amount of PCR product can be used to determine the viral load. • PCR can also be used as a prognostic tool to determine viral load. • This method can also be used to determine the effectiveness antiviral therapy.

  31. DNA Fingerprinting (RFLP) • RFLP = Restriction Fragment Length Polymorphism • Regular fingerprinting analyses phenotypic traits. • DNA fingerprinting analyses genotypic traits. • DNA fingerprinting (DNA typing) is used to characterize biological samples e.g. • In legal proceedings to identify suspects and clear others. • Paternity testing

  32. DNA Fingerprinting (RFLP) • The procedure involves: • Collection of sample e.g. hair, blood, semen, and skin. • Examination of sample to determine if there is enough DNA for the test. • The DNA is digested with restriction enzymes. • Digested DNA is separated by agarose gel electrophoresis. • DNA is transferred by Southern blottingto a membrane. • Membrane is hybridizedwith 4-5 different probes. • Detectionof hybridization.

  33. Minisatellite DNA • After hybridization the membranes are stripped and reprobed. • The probes used are human minisatelliteDNA. • These sequences occur in the human genome as repeated sequences. • e.gATTAG….ATTAG….ATTAG…. • The length of the repeat is 9-40 bases occurring 10-30 times. • The microsatellites have different length and numbers in different individuals. • The variability is due to either a gain or lost of repeats during replication.

  34. Minisatellite DNA • These changes do not have any biological effect because the sequences do not code for any protein. • An individual inherit one microsatellite from each parent. • The chance of finding two individuals within the same population with the same DNA fingerprint is one in 105 - 108. • In other words an individuals DNA fingerprint is almost as uniqueas his or her fingerprint.

  35. DNA Fingerprinting

  36. Random Amplified Polymorphic DNA (RAPD) • Another method widely used in characterization of DNA isRAPD. • RAPD is often used to show relatednessamong DNA populations. • In this procedure arbitrary (random) primers are used during PCR to produce a fingerprint of the DNA. • A single primer is used which must anneal in 2 places on the DNA template and region between the primers will be amplified.

  37. RAPD • The primers are likely to anneal in many placeson the template DNA and will produce a variety of sizesof amplified products. • Amplified products are separated by agarose gel electrophoresis and visualized. • If the samples have similar genetic make up then the pattern of bands on the gel will be similar and vice versa. • This procedure is widely used to differentiate between different cultivars/varieties of the same plant. • Issues to consider when using this procedure include reproducibility, quality of DNA, and several primers may have to be used.

  38. RAPD Analyses

  39. RAPD

  40. Bacterial Biosensors • Bacterial sensors can be used to test for environmental pollutants. • Bacteria with bioluminescent are good candidates for pollutant sensors. • In the presence of pollutants the bioluminescent decreases. • The structural genes (luxCDABD) (vibriofischeri) encodes the enzyme for bioluminescent was cloned into the soil bacteria Pseudomonas fluorescens. • The cells that luminescence to the greatest extent and grew as well as the wild type were tested as pollutant sensors.

  41. Bacterial Biosensors • To screen water samples for pollutants (metal or organic) a suspension of P. fluorescenswas mixed with the solution to be tested. • After a 15 min incubation the luminescence of the suspension was measured in luminometer. • When the solution contained low to moderate levels of pollutants the bioluminescence was inhibited. • The procedure is rapid, simple, cheap and a good screen for pollutants.

  42. Bacterial Bisensor

  43. Restriction Digest Analysis(Molecular Diagnosis of Genetic disease) • Diagnosis of sickle cell anemia. • Sickle cell anemia is a genetic disease which is caused by a single nucleotide change in the 6thaa of the  chain of hemoglobin. • A (normal) glutamic acid and S (sickle) valine. • In the homozygous state SS the red blood cells are irregularly shaped. • The disease results in progressive anemia and damage to heart, lung, brain, joints and other organ systems. • This occurs because the mutant hemoglobin is unable to carry enough oxygento supply these systems.

  44. Diagnosis of Sickle Cell Anemia • The single mutation in hemoglobin cause a change in the restriction pattern of the  globin gene abolishing a CvnI site. • CvnIsite CCTNAGG (N = any nt) • Normal DNA sequence CCTGAGG (A) • Mutant DNA sequence CCTGTGG (S) • Two primers which flank the mutant region of the  globin gene is used during PCR to amplify this region of the gene. • The PCR products is digested with CvnI and separated by agarose gel electrophoresis.

  45. Detection of Sickle cell anemia by PCR

  46. Cystic Fibrosis: • Autosomal recessive Common in Europe, • 500 mutation CFTR gene: (Cystic Fibrosis transmembrane conductance regulator) • Four the most common 81%.

  47. PCR/OLA • Like sickle cell anemia many genetic diseases are caused by mutant genes. • Many diseases are caused by a single nucleotide (nt) change in the wild type gene. • A single nt change can be detected by PCR/OLA ( oligonucleotide ligation assay). • e.g. The normal gene has A at nt position 106 and mutant has a G. • 2 short oligonucleotides (oligo) are synthesized • Oligo 1 (probe x) is complementary to the wild type has A at 106 (3’ end).

  48. PCR/OLA • Oligo 2 ( probe y) has G at 107 (5’ end). • The two probes are incubated with the PCR amplified target DNA. • For the wild type the two probes anneal so that the 3’end of probe x is next to the 5’end of probe y. • For the mutant gene the nt at the 3’ end of probe x is a mismatch and does not anneal.

  49. PCR/OLA

More Related